Iodine123MIBGQualityChecker

Iodine-123 MIBG

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity iodine
Open selection

Utility description: Iodine-123 MIBG

Iodine-123 MIBG Quality Checker — Iodine-123 Metaiodobenzylguanidine

ℹ️  Utility checks critical parameters of Iodine-123 MIBG radiopharmaceutical:
    • Radiochemical purity (≥95%)
    • Free Iodine-123 impurity (≤5%)
    • Radionuclidic impurity Iodine-124 (≤0.5%)
    • Radionuclidic impurity Iodine-125 (≤0.5%)
    • Specific activity, pH (4.0–6.0), endotoxins, sterility

⚠️  CRITICAL: Free iodine accumulates in the thyroid, stomach, and salivary glands, creating high background and artifacts.
    I-124 impurity (>0.5%) significantly increases patient radiation dose due to high-energy emissions.

Usage:
  Iodine123MIBGQualityChecker.exe                            → demo mode (console output)
  Iodine123MIBGQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,AppearanceScore

Example (sterility: 0=sterile, 1=contaminated, appearance: 0=normal):
  I123-MIBG-2026-001,98.0,1.5,0.2,0.1,25.0,5.5,60.0,0,0

— WHY IS THIS NEEDED?
Iodine-123 MIBG is used for scintigraphy of neuroendocrine tumors (pheochromocytoma, neuroblastoma) and for assessing cardiac sympathetic innervation (heart failure, Parkinson's disease).
• MIBG is a norepinephrine analog taken up by adrenergic neurons via the NET transporter.
• I-123 (T½=13.2 hours) provides high-quality gamma imaging.

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures specific uptake by target tissues.
• Free Iodine-123 ≤5% — requires mandatory thyroid blocking with potassium iodide prior to administration.
• I-124 impurity ≤0.5% — control of cyclotron production quality.
• pH 4.0–6.0 — product stability.
• Sterility and apyrogenicity — mandatory for IV injection.

Key features:
• Control of radionuclidic impurities (I-124/I-125).
• Labeling efficiency assessment (RCP).
• Physicochemical parameter check (pH, appearance).

Critical parameters:
• Radiochemical purity: ≥95.0%
• Free Iodine-123: ≤5.0%
• I-124 impurity: ≤0.5%
• I-125 impurity: ≤0.5%
• pH: 4.0–6.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth

💡 Usage tips:
1. RCP is determined by TLC (solvent system: acetone or ethanol/ammonia).
2. Patients must be prescribed potassium iodide 24 hours before and after injection to protect the thyroid.
3. Many drugs (tricyclic antidepressants, sympathomimetics) can interfere with MIBG uptake and should be discontinued before the study.

⚠️ Note: MIBG is sensitive to oxidation. The product must be clear and colorless. Turbidity indicates degradation or contamination.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,AppearanceScore
I123-MIBG-2026-001,98.0,1.5,0.2,0.1,25.0,5.5,60.0,0,0
I123-MIBG-2026-002,94.0,5.5,0.6,0.2,20.0,5.8,70.0,0,0

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Iodine123MIBGQualityChecker for Iodine-123 MIBG.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Iodine-123 MIBG radiopharmaceutical:
  • • Radiochemical purity (≥95%)
  • • Free Iodine-123 impurity (≤5%)
  • • Radionuclidic impurity Iodine-124 (≤0.5%)
  • • Radionuclidic impurity Iodine-125 (≤0.5%)
  • • Specific activity, pH (4.0–6.0), endotoxins, sterility
  • ⚠️ CRITICAL: Free iodine accumulates in the thyroid, stomach, and salivary glands, creating high background and artifacts.
  • I-124 impurity (>0.5%) significantly increases patient radiation dose due to high-energy emissions.
  • BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,AppearanceScore
  • Example (sterility: 0=sterile, 1=contaminated, appearance: 0=normal):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥95% — ensures specific uptake by target tissues.
  • • Free Iodine-123 ≤5% — requires mandatory thyroid blocking with potassium iodide prior to administration.
  • • I-124 impurity ≤0.5% — control of cyclotron production quality.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Iodine-123 MIBG using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringI123-MIBG-2026-001Batch or lot identifier used for traceability.
2RadiochemicalPurityPercentstring98.0Radiochemical purity; confirms the labelled chemical form and binding quality.
3FreeIodine123Percentdecimal1.5Free radionuclide / unbound species; important for non-target uptake and toxicity.
4RadionuclidicPurityI124Percentstring0.2Radionuclidic purity; a critical radiation-safety and impurity parameter.
5RadionuclidicPurityI125Percentstring0.1Radionuclidic purity; a critical radiation-safety and impurity parameter.
6SpecificActivityMBqPerUgdecimal25.0Radioactivity value used for release, decay or dose-related assessment.
7pHdecimal5.5Solution pH; relevant for stability, compatibility and administration.
8EndotoxinsEUdecimal60.0Bacterial endotoxins; critical for parenteral administration.
9SterilityTestflag / boolean0Sterility result; critical release parameter.
10AppearanceScorestring0Visual appearance / clarity parameter.
BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityMBqPerUg,pH,EndotoxinsEU,SterilityTest,AppearanceScore
I123-MIBG-2026-001,98.0,1.5,0.2,0.1,25.0,5.5,60.0,0,0
I123-MIBG-2026-002,94.0,5.5,0.6,0.2,20.0,5.8,70.0,0,0

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Iodine-123 MIBG, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "iodine123-mibg-quality-checker",
  "api": "Iodine-123 MIBG",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "I123-MIBG-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeIodine123Percent",
      "value": "1.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityI124Percent",
      "value": "0.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityI125Percent",
      "value": "0.1",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificActivityMBqPerUg",
      "value": "25.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "5.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "60.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Neurology QC Suite

QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: radioiodine

I-123, I-124, I-125 and I-131 for diagnostics, therapy, labelling and purity control.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: cardiovascular

Myocardial perfusion, cardiac PET/SPECT, ventricular function, blood-pool and perfusion tracers.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: generators, isotope purity and starting radionuclides

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open